Sign in

CIK 0001680367

  • Non-accelerated filer
  • Smaller reporting company

Shattuck Labs, Inc.

Sign in to watch
Ticker
STTK
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
812575858
Phone
+1 512-900-4690
Business address
500 W. 5TH STREET, AUSTIN, TX, 78701
Former names
Shattuck Labs, Inc.
  1. 4 Open-market sale Director sold 17,824 shares at an average $27.46 ($489,449)
  2. 4 Open-market sale Director sold 18,990 shares at an average $26.29 ($499,173)
  3. 4 Open-market sale Chief Executive Officer sold 10,545 shares at an average $25.36 ($267,392)
  4. 4 Open-market sale Director sold 16,592 shares at an average $25.24 ($418,809)
  5. 4 Open-market sale Chief Executive Officer sold 20,170 shares at an average $25.55 ($515,362)
  6. 4 Open-market sale Director sold 20,386 shares at an average $25.57 ($521,244)
  7. 4 Open-market sale General Counsel sold 4,000 shares at $26.25 ($104,982)
  8. 4 Open-market sale Chief Financial Officer sold 2,000 shares at $26.27 ($52,542)
  9. 4 Open-market sale Chief Executive Officer sold 27,072 shares at an average $26.13 ($707,494)
  10. 4 Open-market sale Director sold 27,521 shares at an average $26.12 ($718,855)
  11. 4 Other disposition Director disposed of 673,107 shares (other)
  12. 4 Option exercise Chief Financial Officer acquired 8,860 shares (option exercise)
  13. 4 Open-market sale Chief Executive Officer sold 37,213 shares at an average $27.52 ($1,023,927)
  14. 4 Open-market sale Director sold 37,324 shares at an average $27.51 ($1,026,636)
  15. 4 Open-market sale Chief Financial Officer sold 20,000 shares at $35.00 ($700,000)
  16. 4 Open-market sale General Counsel sold 5,000 shares at $35.00 ($175,000)
  17. 4 Open-market sale Chief Financial Officer sold 24,000 shares at $30.74 ($737,760)
  18. 4 Open-market sale General Counsel sold 7,000 shares at $30.77 ($215,390)
  19. 4 Option exercise Chief Medical Officer acquired 1,604 shares (option exercise)
  20. 4 Derivatives Options or other derivatives

Page 9 of 11 · 211 filings